Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pingfu Fu

Showing results (201-210 of 268) with videos related to

Pageof 27
Sort By:
European Radiology|September 18, 2020
Correction to: T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathologyRakesh Shiradkar, Ananya Panda, Patrick Leo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed-Platinum-Radiation in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer: Results of a Phase I TrialTithi Biswas, Afshin Dowlati, Charles A Kunos, et al.
Plos One|April 8, 2014
Indices to measure risk of HIV acquisition in Rakai, UgandaJoseph Kagaayi, Ronald H Gray, Christopher Whalen, et al.
Bone Marrow Transplantation|October 22, 2020
Correction: History of drug use in allogeneic hematopoietic cell transplant recipientsMouhamed Yazan Abou-Ismail, Gayathri Ravi, Pingfu Fu, et al.
Stem Cells (Dayton, Ohio)|November 29, 2002
Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layerSuzanne Kadereit, Linda S Deeds, Stephen E Haynesworth, et al.
NPJ Precision Oncology|August 28, 2025
Collagen disorder architecture features are associated with clinical, molecular, genetic factors and survival outcomes in colon cancerReetoja Nag, Chuheng Chen, Haider Mejbel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2004
High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortalityPunit D Wadhwa, Pingfu Fu, Omer N Koc, et al.
JAMA Network Open|May 1, 2025
Deep Learning Model of Primary Tumor and Metastatic Cervical Lymph Nodes From CT for Outcome Predictions in Oropharyngeal CancerBolin Song, Amaury Leroy, Kailin Yang, et al.
The Oncologist|November 26, 2025
Immune-related adverse events, survival outcomes, and next steps in patients with stage III melanoma: real-world experience at a National Cancer Institute-designated Comprehensive Cancer CenterKevin G Zablonski, Jarred M Boone, Seunghee Margevicius, et al.
Bone Marrow Transplantation|September 18, 2020
History of drug use in allogeneic hematopoietic cell transplant recipientsMouhamed Yazan Abou-Ismail, Gayathri Ravi, Pingfu Fu, et al.
Pageof 27

Showing results (201-210 of 268) with videos related to

Sort By:
Pageof 27
European Radiology|September 18, 2020
Correction to: T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathologyRakesh Shiradkar, Ananya Panda, Patrick Leo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed-Platinum-Radiation in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer: Results of a Phase I TrialTithi Biswas, Afshin Dowlati, Charles A Kunos, et al.
Plos One|April 8, 2014
Indices to measure risk of HIV acquisition in Rakai, UgandaJoseph Kagaayi, Ronald H Gray, Christopher Whalen, et al.
Bone Marrow Transplantation|October 22, 2020
Correction: History of drug use in allogeneic hematopoietic cell transplant recipientsMouhamed Yazan Abou-Ismail, Gayathri Ravi, Pingfu Fu, et al.
Stem Cells (Dayton, Ohio)|November 29, 2002
Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layerSuzanne Kadereit, Linda S Deeds, Stephen E Haynesworth, et al.
NPJ Precision Oncology|August 28, 2025
Collagen disorder architecture features are associated with clinical, molecular, genetic factors and survival outcomes in colon cancerReetoja Nag, Chuheng Chen, Haider Mejbel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 31, 2004
High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: an effective regimen with low morbidity and mortalityPunit D Wadhwa, Pingfu Fu, Omer N Koc, et al.
JAMA Network Open|May 1, 2025
Deep Learning Model of Primary Tumor and Metastatic Cervical Lymph Nodes From CT for Outcome Predictions in Oropharyngeal CancerBolin Song, Amaury Leroy, Kailin Yang, et al.
The Oncologist|November 26, 2025
Immune-related adverse events, survival outcomes, and next steps in patients with stage III melanoma: real-world experience at a National Cancer Institute-designated Comprehensive Cancer CenterKevin G Zablonski, Jarred M Boone, Seunghee Margevicius, et al.
Bone Marrow Transplantation|September 18, 2020
History of drug use in allogeneic hematopoietic cell transplant recipientsMouhamed Yazan Abou-Ismail, Gayathri Ravi, Pingfu Fu, et al.
Pageof 27